SCHEMBL1726425

SCHEMBL1726425

N#Cc1c(C2CCNCC2)cc(-c2c(O)cccc2OCC2CC2)nc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 20/20 1.00
CHUK O15111 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30337765 1.00 IKBKB (1.00) IKBKBCHUK
Hydrochloric Acid SCHEMBL30341860 0.99 IKBKB (0.98) IKBKBCHUK
SCHEMBL4601439 0.96 IKBKB (1.00) IKBKBCHUK
SCHEMBL14028397 0.91 IKBKB (1.00) IKBKBCHUK
SCHEMBL14028386 0.89 IKBKB (1.00) IKBKBCHUK
SCHEMBL4600994 0.89 IKBKB (1.00) IKBKBCHUK
SCHEMBL7104692 0.89 IKBKB (0.80) IKBKBCHUK
Hydrochloric Acid SCHEMBL4945309 0.89 IKBKB (0.98) IKBKBCHUK
SCHEMBL14028393 0.88 IKBKB (1.00) IKBKBCHUK
SCHEMBL14491978 0.88 IKBKB (1.00) IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087695-A1 TREATMENT FOR METABOLIC DISORDER SAPREME TECHNOLOGIES B.V. (NL) 2026-04-30 WO claimed
WO-2026087680-A1 TREATMENT FOR CARDIOVASCULAR DISEASE SAPREME TECHNOLOGIES B.V. (NL) 2026-04-30 WO claimed
US-12318729-B2 Enzymatic phase transfer solvent for CO2/H2S capture INDIAN OIL CORPORATION LIMITED (IN) 2025-06-03 US claimed
US-20250082652-A1 SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES UNIVERSITÄT ZU KÖLN (DE) 2025-03-13 US claimed
CN-119575816-A Intelligent building energy management method, system, equipment and medium 中国长江三峡集团有限公司 2025-03-07 CN claimed
US-20250079848-A1 METHOD FOR MANAGING HEAT-ELECTRIC OUTPUTS OF HIGH-PROPORTION NEW ENERGY SYSTEM BASED ON CSP-CHP COMBINED ENERGY SUPPLY AND SYSTEM THEREOF SHANDONG UNIVERSITY (CN) 2025-03-06 US claimed
WO-2024250851-A1 ELECTROTHERMAL COLLABORATIVE CONTROL METHOD AND SYSTEM FOR ELECTRIC VEHICLE, AND ENERGY ROUTER 西安交通大学 2024-12-12 WO claimed
EP-3810176-B1 CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION RA PHARMACEUTICALS INC (US) 2024-12-11 EP claimed
EP-4460301-A1 SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES Universität zu Köln (DE) 2024-11-13 EP claimed
US-20240370604-A1 METHOD AND APPARATUS FOR OPTIMALLY CONFIGURING CAPACITY OF HIGH-PROPORTION NEW ENERGY SYSTEM, DEVICE, AND MEDIUM SHANDONG UNIVERSITY (CN) 2024-11-07 US claimed
CN-114693101-A Multi-zone thermoelectric coordination control method for multi-agent reinforcement learning and double-layer strategy distribution 浙江英集动力科技有限公司 2022-07-01 CN claimed
US-20220110953-A1 METHODS AND COMPOSITIONS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED CANCERS THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2022-04-14 US claimed
CN-114155103-A Energy sharing alliance flexibility transaction method based on block chain cooperation game 国网新疆电力有限公司电力科学研究院 2022-03-08 CN claimed
US-20180117067-A1 METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS BAYLOR RESEARCH INSTITUTE 2018-05-03 US claimed
WO-2016160880-A1 METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS BAYLOR RESEARCH INSTITUTE (US) 2016-10-06 WO claimed
CN-101842095-A Formulations, methods and targets for tumor therapy MING YU 2010-09-22 CN claimed
EP-2178531-A2 METHODS, COMPOSITION, TARGETS FOR COMBINATIONAL CANCER TREATMENTS Yu, Ming (US) 2010-04-28 EP claimed
WO-2009006555-A2 METHODS, COMPOSITION, TARGETS FOR COMBINATIONAL CANCER TREATMENTS YU, MING (US) 2009-01-08 WO claimed
EP-1326856-B1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-BETA) INHIBITING ACTIVITY BAYER HEALTHCARE AG (DE) 2007-12-19 EP claimed
US-6984649-B1 Pyridine derivatives BAYER AKTIENGESELLSCHAFT (DE) 2006-01-10 US claimed